Patents by Inventor Mee Sup Yoon

Mee Sup Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXOSOME-DERIVED MICRORNA BIOMARKER FOR DIAGNOSIS OF PREMATURE OVARIAN INSUFFICIENCY (POI) AND USE THEREOF
    Publication number: 20240401135
    Abstract: By using the biomarker of the present invention, early diagnosis of premature ovarian insufficiency is possible, diagnosis differentiating between premature ovarian insufficiency and premature ovarian insufficiency caused by Turner syndrome is possible, and a method for screening a therapeutic agent for premature ovarian insufficiency through a change in the expression of the biomarker can be provided.
    Type: Application
    Filed: March 29, 2024
    Publication date: December 5, 2024
    Applicant: GIL MEDICAL CENTER
    Inventors: Mee-Sup YOON, Seung-Joo CHON, Zobia UMAIR
  • Composition comprising UNE-L domain of leucyl-tRNA synthetase as effective ingredient for augmenting muscle
    Patent number: 11389516
    Abstract: The present invention relates to a composition comprising the UNE-L domain of leucyl-tRNA synthetase as an effective ingredient for increasing muscle. More particularly, the UNE-L domain of LRS according to the present invention, which is a region that controls activity of Vps34, activates mTORC1 involved in protein synthesis and increases myocyte differentiation and muscle fiber regeneration, thus finding useful application in muscle augmentation.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: July 19, 2022
    Assignees: Gachon University of Industry-Academic Cooperation Foundation, Gil Medical Center
    Inventors: Mee Sup Yoon, Jie Chen, Kook Son, Cheol Soo Choi, Sunghoon Kim, Jung Min Han
  • COMPOSITION COMPRISING UNE-L DOMAIN OF LEUCYL-TRNA SYNTHETASE AS EFFECTIVE INGREDIENT FOR AUGMENTING MUSCLE
    Publication number: 20200155655
    Abstract: The present invention relates to a composition comprising the UNE-L domain of leucyl-tRNA synthetase as an effective ingredient for increasing muscle. More particularly, the UNE-L domain of LRS according to the present invention, which is a region that controls activity of Vps34, activates mTORC1 involved in protein synthesis and increases myocyte differentiation and muscle fiber regeneration, thus finding useful application in muscle augmentation.
    Type: Application
    Filed: November 8, 2019
    Publication date: May 21, 2020
    Inventors: Mee Sup Yoon, Jie Chen, Kook Son, Cheol Soo Choi, Sunghoon Kim, Jung Min Han